+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Contract Research Organization (CRO) Market 2025-2029

  • PDF Icon

    Report

  • 206 Pages
  • December 2024
  • Region: Global
  • TechNavio
  • ID: 5578818
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The contract research organization (CRO) market is forecasted to grow by USD 85.3 billion during 2024-2029, accelerating at a CAGR of 14.6% during the forecast period. The report on the contract research organization (CRO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, increasing prevalence of chronic diseases, and increase in mergers and acquisitions activities by vendors.

The contract research organization (CRO) market is segmented as below:

By Application

  • Clinical research
  • Early phase development
  • Laboratory
  • Regulatory consulting

By End-user

  • Pharmaceutical and biopharmaceutical companies
  • Medical device companies
  • Academic institutes

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the increasing number of clinical trials as one of the prime reasons driving the contract research organization (CRO) market growth during the next few years. Also, rise in vaccines production and growing outsourcing and cost savings through use of cro services will lead to sizable demand in the market.

The report on the contract research organization (CRO) market covers the following areas:

  • Contract Research Organization (CRO) Market sizing
  • Contract Research Organization (CRO) Market forecast
  • Contract Research Organization (CRO) Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading contract research organization (CRO) market vendors that include BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service B.V., CTI Clinical Trial and Consulting Inc., Ergomed Plc, Eurofins Scientific SE, Geneticist Inc., Hangzhou Tigermed Consulting Co. Ltd., ICON plc, IQVIA Holdings Inc., Konecranes, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Novotech Health Holdings, Parexel International Corp., Pharmaron Beijing Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd. Also, the contract research organization (CRO) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ billion)
Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Contract Research Organization (CRO) Market 2019 - 2023
Historic Market Size - Data Table on Global Contract Research Organization (CRO) Market 2019 - 2023 ($ billion)
5.2 Application segment analysis 2019 - 2023
Historic Market Size - Application Segment 2019 - 2023 ($ billion)
5.3 End-user segment analysis 2019 - 2023
Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
5.4 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.5 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI on Global Contract Research Organization (CRO) Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Clinical research - Market size and forecast 2024-2029
Chart on Clinical research - Market size and forecast 2024-2029 ($ billion)
Data Table on Clinical research - Market size and forecast 2024-2029 ($ billion)
Chart on Clinical research - Year-over-year growth 2024-2029 (%)
Data Table on Clinical research - Year-over-year growth 2024-2029 (%)
8.4 Early phase development - Market size and forecast 2024-2029
Chart on Early phase development - Market size and forecast 2024-2029 ($ billion)
Data Table on Early phase development - Market size and forecast 2024-2029 ($ billion)
Chart on Early phase development - Year-over-year growth 2024-2029 (%)
Data Table on Early phase development - Year-over-year growth 2024-2029 (%)
8.5 Laboratory - Market size and forecast 2024-2029
Chart on Laboratory - Market size and forecast 2024-2029 ($ billion)
Data Table on Laboratory - Market size and forecast 2024-2029 ($ billion)
Chart on Laboratory - Year-over-year growth 2024-2029 (%)
Data Table on Laboratory - Year-over-year growth 2024-2029 (%)
8.6 Regulatory consulting - Market size and forecast 2024-2029
Chart on Regulatory consulting - Market size and forecast 2024-2029 ($ billion)
Data Table on Regulatory consulting - Market size and forecast 2024-2029 ($ billion)
Chart on Regulatory consulting - Year-over-year growth 2024-2029 (%)
Data Table on Regulatory consulting - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Application
Market opportunity by Application ($ billion)
Data Table on Market opportunity by Application ($ billion)
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2024-2029 (%)
Data Table on End-user - Market share 2024-2029 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029
Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ billion)
Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ billion)
Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
9.4 Medical device companies - Market size and forecast 2024-2029
Chart on Medical device companies - Market size and forecast 2024-2029 ($ billion)
Data Table on Medical device companies - Market size and forecast 2024-2029 ($ billion)
Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
9.5 Academic institutes - Market size and forecast 2024-2029
Chart on Academic institutes - Market size and forecast 2024-2029 ($ billion)
Data Table on Academic institutes - Market size and forecast 2024-2029 ($ billion)
Chart on Academic institutes - Year-over-year growth 2024-2029 (%)
Data Table on Academic institutes - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by End-user
Market opportunity by End-user ($ billion)
Data Table on Market opportunity by End-user ($ billion)
10 Customer Landscape
10.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
11.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ billion)
Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ billion)
Data Table on US - Market size and forecast 2024-2029 ($ billion)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ billion)
Data Table on China - Market size and forecast 2024-2029 ($ billion)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
11.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.10 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ billion)
Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
11.12 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ billion)
Data Table on France - Market size and forecast 2024-2029 ($ billion)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
11.13 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ billion)
Data Table on India - Market size and forecast 2024-2029 ($ billion)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
11.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.15 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
11.16 UAE - Market size and forecast 2024-2029
Chart on UAE - Market size and forecast 2024-2029 ($ billion)
Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
Chart on UAE - Year-over-year growth 2024-2029 (%)
Data Table on UAE - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ billion)
Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints
12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 BioAgile Therapeutics Pvt. Ltd
BioAgile Therapeutics Pvt. Ltd - Overview
BioAgile Therapeutics Pvt. Ltd - Product / Service
BioAgile Therapeutics Pvt. Ltd - Key offerings
SWOT
14.5 Charles River Laboratories International Inc.
Charles River Laboratories International Inc. - Overview
Charles River Laboratories International Inc. - Business segments
Charles River Laboratories International Inc. - Key offerings
Charles River Laboratories International Inc. - Segment focus
SWOT
14.6 CTI Clinical Trial and Consulting Inc.
CTI Clinical Trial and Consulting Inc. - Overview
CTI Clinical Trial and Consulting Inc. - Product / Service
CTI Clinical Trial and Consulting Inc. - Key offerings
SWOT
14.7 Ergomed Plc
Ergomed Plc - Overview
Ergomed Plc - Product / Service
Ergomed Plc - Key offerings
SWOT
14.8 Eurofins Scientific SE
Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key news
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
SWOT
14.9 ICON plc
ICON plc - Overview
ICON plc - Product / Service
ICON plc - Key offerings
SWOT
14.10 IQVIA Holdings Inc.
IQVIA Holdings Inc. - Overview
IQVIA Holdings Inc. - Business segments
IQVIA Holdings Inc. - Key news
IQVIA Holdings Inc. - Key offerings
IQVIA Holdings Inc. - Segment focus
SWOT
14.11 Konecranes
Konecranes - Overview
Konecranes - Business segments
Konecranes - Key news
Konecranes - Key offerings
Konecranes - Segment focus
SWOT
14.12 Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings - Overview
Laboratory Corp. of America Holdings - Business segments
Laboratory Corp. of America Holdings - Key news
Laboratory Corp. of America Holdings - Key offerings
Laboratory Corp. of America Holdings - Segment focus
SWOT
14.13 Medpace Holdings Inc.
Medpace Holdings Inc. - Overview
Medpace Holdings Inc. - Product / Service
Medpace Holdings Inc. - Key offerings
SWOT
14.14 Novotech Health Holdings
Novotech Health Holdings - Overview
Novotech Health Holdings - Product / Service
Novotech Health Holdings - Key offerings
SWOT
14.15 Parexel International Corp.
Parexel International Corp. - Overview
Parexel International Corp. - Product / Service
Parexel International Corp. - Key offerings
SWOT
14.16 Syneos Health Inc.
Syneos Health Inc. - Overview
Syneos Health Inc. - Product / Service
Syneos Health Inc. - Key offerings
SWOT
14.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
14.18 WuXi AppTec Co. Ltd.
WuXi AppTec Co. Ltd. - Overview
WuXi AppTec Co. Ltd. - Business segments
WuXi AppTec Co. Ltd. - Key offerings
WuXi AppTec Co. Ltd. - Segment focus
SWOT
15 Appendix
15.1 Scope of the report
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 11: Overview on criticality of inputs and factors of differentiation
Exhibits 12: Overview on factors of disruption
Exhibits 13: Impact of drivers and challenges in 2024 and 2029
Exhibits 14: Parent Market
Exhibits 15: Data Table on - Parent Market
Exhibits 16: Market characteristics analysis
Exhibits 17: Value chain analysis
Exhibits 18: Offerings of companies included in the market definition
Exhibits 19: Market segments
Exhibits 20: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 21: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits 22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Historic Market Size - Data Table on Global Contract Research Organization (CRO) Market 2019 - 2023 ($ billion)
Exhibits 25: Historic Market Size - Application Segment 2019 - 2023 ($ billion)
Exhibits 26: Historic Market Size - End-user Segment 2019 - 2023 ($ billion)
Exhibits 27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits 28: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits 29: Five forces analysis - Comparison between 2024 and 2029
Exhibits 30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 35: Chart on Market condition - Five forces 2024 and 2029
Exhibits 36: Chart on Application - Market share 2024-2029 (%)
Exhibits 37: Data Table on Application - Market share 2024-2029 (%)
Exhibits 38: Chart on Comparison by Application
Exhibits 39: Data Table on Comparison by Application
Exhibits 40: Chart on Clinical research - Market size and forecast 2024-2029 ($ billion)
Exhibits 41: Data Table on Clinical research - Market size and forecast 2024-2029 ($ billion)
Exhibits 42: Chart on Clinical research - Year-over-year growth 2024-2029 (%)
Exhibits 43: Data Table on Clinical research - Year-over-year growth 2024-2029 (%)
Exhibits 44: Chart on Early phase development - Market size and forecast 2024-2029 ($ billion)
Exhibits 45: Data Table on Early phase development - Market size and forecast 2024-2029 ($ billion)
Exhibits 46: Chart on Early phase development - Year-over-year growth 2024-2029 (%)
Exhibits 47: Data Table on Early phase development - Year-over-year growth 2024-2029 (%)
Exhibits 48: Chart on Laboratory - Market size and forecast 2024-2029 ($ billion)
Exhibits 49: Data Table on Laboratory - Market size and forecast 2024-2029 ($ billion)
Exhibits 50: Chart on Laboratory - Year-over-year growth 2024-2029 (%)
Exhibits 51: Data Table on Laboratory - Year-over-year growth 2024-2029 (%)
Exhibits 52: Chart on Regulatory consulting - Market size and forecast 2024-2029 ($ billion)
Exhibits 53: Data Table on Regulatory consulting - Market size and forecast 2024-2029 ($ billion)
Exhibits 54: Chart on Regulatory consulting - Year-over-year growth 2024-2029 (%)
Exhibits 55: Data Table on Regulatory consulting - Year-over-year growth 2024-2029 (%)
Exhibits 56: Market opportunity by Application ($ billion)
Exhibits 57: Data Table on Market opportunity by Application ($ billion)
Exhibits 58: Chart on End-user - Market share 2024-2029 (%)
Exhibits 59: Data Table on End-user - Market share 2024-2029 (%)
Exhibits 60: Chart on Comparison by End-user
Exhibits 61: Data Table on Comparison by End-user
Exhibits 62: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ billion)
Exhibits 63: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2024-2029 ($ billion)
Exhibits 64: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Exhibits 65: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2024-2029 (%)
Exhibits 66: Chart on Medical device companies - Market size and forecast 2024-2029 ($ billion)
Exhibits 67: Data Table on Medical device companies - Market size and forecast 2024-2029 ($ billion)
Exhibits 68: Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
Exhibits 69: Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
Exhibits 70: Chart on Academic institutes - Market size and forecast 2024-2029 ($ billion)
Exhibits 71: Data Table on Academic institutes - Market size and forecast 2024-2029 ($ billion)
Exhibits 72: Chart on Academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 73: Data Table on Academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits 74: Market opportunity by End-user ($ billion)
Exhibits 75: Data Table on Market opportunity by End-user ($ billion)
Exhibits 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 77: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 78: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 79: Chart on Geographic comparison
Exhibits 80: Data Table on Geographic comparison
Exhibits 81: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 82: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits 83: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 84: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 85: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 86: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits 87: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 88: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 89: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 90: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits 91: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 92: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 93: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 94: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits 95: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 98: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits 99: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 102: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits 103: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 106: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits 107: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 110: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits 111: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 114: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits 115: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 118: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits 119: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 122: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits 123: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 126: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits 127: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 130: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion)
Exhibits 131: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on UAE - Market size and forecast 2024-2029 ($ billion)
Exhibits 134: Data Table on UAE - Market size and forecast 2024-2029 ($ billion)
Exhibits 135: Chart on UAE - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on UAE - Year-over-year growth 2024-2029 (%)
Exhibits 137: Market opportunity By Geographical Landscape ($ billion)
Exhibits 138: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 139: Impact of drivers and challenges in 2024 and 2029
Exhibits 140: Overview on criticality of inputs and factors of differentiation
Exhibits 141: Overview on factors of disruption
Exhibits 142: Impact of key risks on business
Exhibits 143: Companies covered
Exhibits 144: Company ranking index
Exhibits 145: Matrix on companies position and classification
Exhibits 146: BioAgile Therapeutics Pvt. Ltd - Overview
Exhibits 147: BioAgile Therapeutics Pvt. Ltd - Product / Service
Exhibits 148: BioAgile Therapeutics Pvt. Ltd - Key offerings
Exhibits 149: SWOT
Exhibits 150: Charles River Laboratories International Inc. - Overview
Exhibits 151: Charles River Laboratories International Inc. - Business segments
Exhibits 152: Charles River Laboratories International Inc. - Key offerings
Exhibits 153: Charles River Laboratories International Inc. - Segment focus
Exhibits 154: SWOT
Exhibits 155: CTI Clinical Trial and Consulting Inc. - Overview
Exhibits 156: CTI Clinical Trial and Consulting Inc. - Product / Service
Exhibits 157: CTI Clinical Trial and Consulting Inc. - Key offerings
Exhibits 158: SWOT
Exhibits 159: Ergomed Plc - Overview
Exhibits 160: Ergomed Plc - Product / Service
Exhibits 161: Ergomed Plc - Key offerings
Exhibits 162: SWOT
Exhibits 163: Eurofins Scientific SE - Overview
Exhibits 164: Eurofins Scientific SE - Business segments
Exhibits 165: Eurofins Scientific SE - Key news
Exhibits 166: Eurofins Scientific SE - Key offerings
Exhibits 167: Eurofins Scientific SE - Segment focus
Exhibits 168: SWOT
Exhibits 169: ICON plc - Overview
Exhibits 170: ICON plc - Product / Service
Exhibits 171: ICON plc - Key offerings
Exhibits 172: SWOT
Exhibits 173: IQVIA Holdings Inc. - Overview
Exhibits 174: IQVIA Holdings Inc. - Business segments
Exhibits 175: IQVIA Holdings Inc. - Key news
Exhibits 176: IQVIA Holdings Inc. - Key offerings
Exhibits 177: IQVIA Holdings Inc. - Segment focus
Exhibits 178: SWOT
Exhibits 179: Konecranes - Overview
Exhibits 180: Konecranes - Business segments
Exhibits 181: Konecranes - Key news
Exhibits 182: Konecranes - Key offerings
Exhibits 183: Konecranes - Segment focus
Exhibits 184: SWOT
Exhibits 185: Laboratory Corp. of America Holdings - Overview
Exhibits 186: Laboratory Corp. of America Holdings - Business segments
Exhibits 187: Laboratory Corp. of America Holdings - Key news
Exhibits 188: Laboratory Corp. of America Holdings - Key offerings
Exhibits 189: Laboratory Corp. of America Holdings - Segment focus
Exhibits 190: SWOT
Exhibits 191: Medpace Holdings Inc. - Overview
Exhibits 192: Medpace Holdings Inc. - Product / Service
Exhibits 193: Medpace Holdings Inc. - Key offerings
Exhibits 194: SWOT
Exhibits 195: Novotech Health Holdings - Overview
Exhibits 196: Novotech Health Holdings - Product / Service
Exhibits 197: Novotech Health Holdings - Key offerings
Exhibits 198: SWOT
Exhibits 199: Parexel International Corp. - Overview
Exhibits 200: Parexel International Corp. - Product / Service
Exhibits 201: Parexel International Corp. - Key offerings
Exhibits 202: SWOT
Exhibits 203: Syneos Health Inc. - Overview
Exhibits 204: Syneos Health Inc. - Product / Service
Exhibits 205: Syneos Health Inc. - Key offerings
Exhibits 206: SWOT
Exhibits 207: Thermo Fisher Scientific Inc. - Overview
Exhibits 208: Thermo Fisher Scientific Inc. - Business segments
Exhibits 209: Thermo Fisher Scientific Inc. - Key news
Exhibits 210: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 211: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 212: SWOT
Exhibits 213: WuXi AppTec Co. Ltd. - Overview
Exhibits 214: WuXi AppTec Co. Ltd. - Business segments
Exhibits 215: WuXi AppTec Co. Ltd. - Key offerings
Exhibits 216: WuXi AppTec Co. Ltd. - Segment focus
Exhibits 217: SWOT
Exhibits 218: Inclusions checklist
Exhibits 219: Exclusions checklist
Exhibits 220: Currency conversion rates for US$
Exhibits 221: Research methodology
Exhibits 222: Information sources
Exhibits 223: Data validation
Exhibits 224: Validation techniques employed for market sizing
Exhibits 225: Data synthesis
Exhibits 226: 360 degree market analysis
Exhibits 227: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global contract research organization (CRO) market: BioAgile Therapeutics Pvt. Ltd, Charles River Laboratories International Inc., Clinical Trial Service B.V., CTI Clinical Trial and Consulting Inc., Ergomed Plc, Eurofins Scientific SE, Geneticist Inc., Hangzhou Tigermed Consulting Co. Ltd., ICON plc, IQVIA Holdings Inc., Konecranes, Laboratory Corp. of America Holdings, Linical Co. Ltd., Medpace Holdings Inc., Novotech Health Holdings, Parexel International Corp., Pharmaron Beijing Co. Ltd., Syneos Health Inc., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of clinical trials."

According to the report, one of the major drivers for this market is the growth of biopharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • BioAgile Therapeutics Pvt. Ltd
  • Charles River Laboratories International Inc.
  • Clinical Trial Service B.V.
  • CTI Clinical Trial and Consulting Inc.
  • Ergomed Plc
  • Eurofins Scientific SE
  • Geneticist Inc.
  • Hangzhou Tigermed Consulting Co. Ltd.
  • ICON plc
  • IQVIA Holdings Inc.
  • Konecranes
  • Laboratory Corp. of America Holdings
  • Linical Co. Ltd.
  • Medpace Holdings Inc.
  • Novotech Health Holdings
  • Parexel International Corp.
  • Pharmaron Beijing Co. Ltd.
  • Syneos Health Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co. Ltd.